Format

Send to

Choose Destination
Vaccine. 2006 Feb 27;24(9):1413-20. Epub 2005 Sep 22.

Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice.

Author information

1
Bacteriology Division, United States Army Research Institute of Infectious Diseases, Frederick, MD 21702, USA. kei.amemita@det.amedd.army.mil

Abstract

We evaluated the effect of interleukin (IL)-12 on the immune response to Burkholderia mallei in BALB/c mice. Mice were vaccinated with non-viable B. mallei cells with or without IL-12. There was a seven- to nine-fold increase in IgG2a levels, and a significant increase in the proliferative response and interferon (IFN)-gamma production by splenocytes from mice that received B. mallei and IL-12. We saw an increase in survivors in the groups of mice that received B. mallei and IL-12 when challenged, compared to mice that received only B. mallei or IL-12. The results suggest that IL-12 can enhance the Th1-like immune response to B. mallei and mediate limited protection from a lethal challenge.

PMID:
16213631
DOI:
10.1016/j.vaccine.2005.09.021
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center